- info@novaerus.ie
- +353 (1) 255 1536
To evaluate the efficacy of the NV900 on reducing methicillin-resistant Staphylococcus aureus (MRSA).
The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the NV900.
The NV800/NV900 reduced 99.99% of methicillin-resistant Staphylococcus aureus (MRSA) bacteria over the course of four hours.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma NanoStrike technology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
